VIDEO | 03:49
Urologic surgeon Jonathan Coleman discusses how men with Gleason grade 6 (low-risk) prostate tumors may be candidates for focal therapy, an approach that employs a variety of noninvasive techniques to destroy cancerous tissue within the prostate while preserving normal tissue and minimizing the risk of side effects. Dr. Coleman explains how novel imaging approaches are being used to identify men with low-risk disease who may benefit from this approach. Focal therapy is often performed on an outpatient basis or as a single overnight hospital stay.
